This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2010 Sep;5(9):1301-3.

doi: 10.2217/fmb.10.92.

Treatment of visceral leishmaniasis in 2010: direction from Bihar State, India

PMID: 20860475
DOI: 10.2217/fmb.10.92

Editorial

Treatment of visceral leishmaniasis in 2010: direction from Bihar State, India

Henry W Murray. Future Microbiol. 2010 Sep.

. 2010 Sep;5(9):1301-3.

doi: 10.2217/fmb.10.92.

Author

PMID: 20860475
DOI: 10.2217/fmb.10.92

No abstract available

PubMed Disclaimer

Similar articles

Anthropometrically derived dosing and drug costing calculations for treating visceral leishmaniasis in Bihar, India.
Olliaro P, Sundar S. Olliaro P, et al. Trop Med Int Health. 2009 Jan;14(1):88-92. doi: 10.1111/j.1365-3156.2008.02195.x. Epub 2008 Dec 11. Trop Med Int Health. 2009. PMID: 19121150
Cost-effectiveness projections of single and combination therapies for visceral leishmaniasis in Bihar, India.
Olliaro P, Darley S, Laxminarayan R, Sundar S. Olliaro P, et al. Trop Med Int Health. 2009 Aug;14(8):918-25. doi: 10.1111/j.1365-3156.2009.02306.x. Epub 2009 Jun 28. Trop Med Int Health. 2009. PMID: 19563434
Drug combinations for visceral leishmaniasis.
Olliaro PL. Olliaro PL. Curr Opin Infect Dis. 2010 Dec;23(6):595-602. doi: 10.1097/QCO.0b013e32833fca9d. Curr Opin Infect Dis. 2010. PMID: 20871400 Review.
Combination therapy for visceral leishmaniasis.
van Griensven J, Boelaert M. van Griensven J, et al. Lancet. 2011 Feb 5;377(9764):443-4. doi: 10.1016/S0140-6736(10)62237-4. Epub 2011 Jan 20. Lancet. 2011. PMID: 21255829 No abstract available.
Leishmaniasis: an update of current pharmacotherapy.
Sundar S, Chakravarty J. Sundar S, et al. Expert Opin Pharmacother. 2013 Jan;14(1):53-63. doi: 10.1517/14656566.2013.755515. Epub 2012 Dec 21. Expert Opin Pharmacother. 2013. PMID: 23256501 Review.

See all similar articles

Cited by

Need for sustainable approaches in antileishmanial drug discovery.
Hendrickx S, Caljon G, Maes L. Hendrickx S, et al. Parasitol Res. 2019 Oct;118(10):2743-2752. doi: 10.1007/s00436-019-06443-2. Epub 2019 Aug 31. Parasitol Res. 2019. PMID: 31473855 Review.
Leishmania antimony resistance: what we know what we can learn from the field.
Aït-Oudhia K, Gazanion E, Vergnes B, Oury B, Sereno D. Aït-Oudhia K, et al. Parasitol Res. 2011 Nov;109(5):1225-32. doi: 10.1007/s00436-011-2555-5. Epub 2011 Jul 29. Parasitol Res. 2011. PMID: 21800124 Review.
Antileishmanial Activity of Disulfiram and Thiuram Disulfide Analogs in an Ex Vivo Model System Is Selectively Enhanced by the Addition of Divalent Metal Ions.
Peniche AG, Renslo AR, Melby PC, Travi BL. Peniche AG, et al. Antimicrob Agents Chemother. 2015 Oct;59(10):6463-70. doi: 10.1128/AAC.05131-14. Epub 2015 Aug 3. Antimicrob Agents Chemother. 2015. PMID: 26239994 Free PMC article.
Integrated dataset of screening hits against multiple neglected disease pathogens.
Nwaka S, Besson D, Ramirez B, Maes L, Matheeussen A, Bickle Q, Mansour NR, Yousif F, Townson S, Gokool S, Cho-Ngwa F, Samje M, Misra-Bhattacharya S, Murthy PK, Fakorede F, Paris JM, Yeates C, Ridley R, Van Voorhis WC, Geary T. Nwaka S, et al. PLoS Negl Trop Dis. 2011 Dec;5(12):e1412. doi: 10.1371/journal.pntd.0001412. Epub 2011 Dec 20. PLoS Negl Trop Dis. 2011. PMID: 22247786 Free PMC article.
Validation of a simple resazurin-based promastigote assay for the routine monitoring of miltefosine susceptibility in clinical isolates of Leishmania donovani.
Kulshrestha A, Bhandari V, Mukhopadhyay R, Ramesh V, Sundar S, Maes L, Dujardin JC, Roy S, Salotra P. Kulshrestha A, et al. Parasitol Res. 2013 Feb;112(2):825-8. doi: 10.1007/s00436-012-3212-3. Epub 2012 Dec 13. Parasitol Res. 2013. PMID: 23239091

See all "Cited by" articles

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions

Grants and funding

1R01AI083219/AI/NIAID NIH HHS/United States

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.